GRx+Biosims 2020 Conference
GRx+Biosims 2020 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory and policy professionals.
Top officials and subject-matter experts share their knowledge and best practices to enhance attendees’ understanding of how to succeed in generic and biosimilar development; the regulatory process and approvals: and the evolving policy landscape.
The keynote speakers committed to GRx+Biosims 2020 are among our nation’s leading health regulators and authorities. We have confirmed Office of Generic Drug Director Sally Choe, PhD, and Office of Therapeutic Biologics and Biosimilars Director Sarah Yim, M.D., and have invited FDA Commissioner Stephen Hahn, M.D., and CMS Administrator Seema Verma to address the industry.